GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Accounts Receivable

Tci Gene (ROCO:6879) Accounts Receivable : NT$102.6 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Tci Gene Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Tci Gene's accounts receivables for the quarter that ended in Dec. 2023 was NT$102.6 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Tci Gene's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 101.76.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Tci Gene's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was NT$31.17.


Tci Gene Accounts Receivable Historical Data

The historical data trend for Tci Gene's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene Accounts Receivable Chart

Tci Gene Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
32.97 44.74 116.90 71.63 102.59

Tci Gene Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Accounts Receivable Get a 7-Day Free Trial Premium Member Only 116.90 138.68 71.63 65.64 102.59

Tci Gene Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Tci Gene Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Tci Gene's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=102.59/183.992*91
=101.76

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Tci Gene's accounts receivable are only considered to be worth 75% of book value:

Tci Gene's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(899.646+0.75 * 102.59+0.5 * 54.847-155.548
-0-23.88)/26.4585
=31.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Tci Gene Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Tci Gene's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Tci Gene (ROCO:6879) Business Description

Traded in Other Exchanges
N/A
Address
No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN
Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines